NEW YORK, July 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fiserv, Inc. (NYSE: FI). Shareholders who purchased shares of FI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/fiserv-inc-loss-submission-form/?id=158799&from=4 CLASS PERIOD: July 24, 2024 to July 22, 2025 ...

Core Viewpoint - A class action lawsuit has been filed against Organon & Co. for allegedly providing misleading statements to investors while concealing material adverse facts regarding the company's capital allocation priorities, particularly concerning its dividend strategy [2][4]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of all individuals and entities who purchased Organon securities between November 3, 2022, and April 30, 2025, with a deadline of July 22, 2025, for investors to apply as lead plaintiffs [2]. - The lawsuit claims that the defendants made overwhelmingly positive statements while hiding the true state of Organon's priorities, especially regarding its debt reduction strategy after acquiring Dermavant, which led to a 70% decrease in the regular quarterly dividend [4]. Group 2: Stock Price Impact - Following the announcement of the lawsuit and the related disclosures, Organon's stock price fell from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025, marking a decline of over 27% in just one day [5]. Group 3: Investor Communication - Investors who suffered losses or have questions regarding their rights related to the lawsuit are encouraged to contact the law firm Bragar Eagel & Squire for more information [6].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Vestis Corporation regarding a class action lawsuit due to allegations of misleading statements and failure to meet growth expectations, leading to a significant drop in stock price [1][2]. Group 1: Allegations and Financial Impact - The class period for the allegations is from May 2, 2024, to May 6, 2025, during which Vestis Corporation allegedly provided overly positive statements while concealing material adverse facts about its business growth capabilities [2]. - On May 7, 2025, Vestis announced disappointing financial results for Q2 2025, withdrew its revenue guidance for the full fiscal year, and provided lower-than-expected guidance for Q3 2025, attributing the poor performance to "lost business in excess of new business" and "lower adds over stops" [2]. - Following the announcement, Vestis' stock price plummeted from $8.71 per share on May 6, 2025, to $5.44 per share on May 7, 2025, marking a decline of approximately 37.54% in one day [2]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action lawsuit by the deadline of August 8, 2025, to potentially become lead plaintiffs and receive updates on the case [3]. - Registration involves no cost or obligation, and participants will be enrolled in a portfolio monitoring system for status updates throughout the case lifecycle [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [4].

Core Viewpoint - A class action lawsuit has been filed against iRobot Corporation for allegedly making materially false and misleading statements regarding its business and operations during the Class Period from January 29, 2024, to March 11, 2025 [1][3]. Financial Performance - iRobot reported a loss of $2.06 per share on revenue of $172 million for Q4 2024, marking a 44% year-over-year decline [4]. - The company expressed substantial doubt about its ability to continue as a going concern for at least 12 months from the issuance of its 2024 financial statements [4]. Market Reaction - Following the announcement of poor financial results, iRobot's stock price fell by $3.255 per share, or 51.58%, closing at $3.055 per share on March 13, 2025 [5]. - Analysts have downgraded iRobot's stock rating due to a bleak outlook, citing deteriorating business prospects and significant layoffs [5]. Legal Context - Investors who acquired iRobot securities during the Class Period are encouraged to contact Bragar Eagel & Squire, P.C. to discuss their legal rights [1][6].

Core Viewpoint - Hims & Hers Health, Inc. is facing allegations of deceptive practices related to the promotion and sale of illegitimate versions of Wegovy®, which may jeopardize its collaboration with Novo Nordisk and mislead investors about the company's prospects [2]. Group 1: Allegations and Legal Action - The class period for the allegations against Hims & Hers Health, Inc. is from April 29, 2025, to June 23, 2025 [2]. - Allegations include that Hims engaged in deceptive promotion and selling of illegitimate versions of Wegovy®, risking patient safety [2]. - The complaint suggests that the misleading statements made by the defendants about the company's business and operations lacked a reasonable basis [2]. Group 2: Shareholder Information - Shareholders who purchased shares during the class period are encouraged to register for potential lead plaintiff appointment, with a deadline of August 25, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [3]. - Participation in the case incurs no cost or obligation for shareholders [3]. Group 3: Law Firm's Role - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - A class action securities lawsuit has been filed against 3D Systems Corporation, alleging securities fraud that negatively impacted investors between August 13, 2024, and May 12, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that 3D Systems Corporation understated the impact of weakened customer spending on its business while overstating its resilience in challenging industry conditions [2]. - It is also alleged that updated milestone criteria in the partnership with United Therapeutics Corporation would adversely affect the revenue from the Company's regenerative medicine program [2]. - As a result, the Company's public statements were deemed materially false and misleading throughout the relevant period [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 12, 2025, to request to be appointed as lead plaintiff in the case [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Vestis Corporation regarding a class action lawsuit due to allegations of misleading statements and failure to meet growth expectations, resulting in a significant stock price decline [1][2]. Group 1: Allegations and Financial Impact - The class period for the allegations against Vestis Corporation is from May 2, 2024, to May 6, 2025 [2]. - The complaint states that Vestis provided overly positive statements while concealing material adverse facts about its business growth capabilities, particularly its inability to execute strategic initiatives aimed at improving customer experience and retention [2]. - Following the announcement of disappointing financial results for Q2 2025 and the withdrawal of revenue guidance, Vestis' stock price plummeted from $8.71 to $5.44, a decline of approximately 37.54% in one day [2]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action lawsuit by August 8, 2025, to potentially become lead plaintiffs [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. Group 3: Law Firm's Commitment - The Gross Law Firm is dedicated to protecting investors' rights and ensuring companies adhere to responsible business practices, seeking recovery for losses incurred due to misleading statements [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Ibotta, Inc. regarding a class action lawsuit related to misleading statements about the company's contract with Kroger, which could have significant implications for investors [1][2]. Group 1: Allegations and Legal Context - The lawsuit alleges that Ibotta made false statements and failed to disclose the at-will nature of its contract with Kroger, which could allow Kroger to terminate the contract without warning [2]. - Ibotta provided detailed information about its contract with Walmart but did not adequately warn investors about the risks associated with the Kroger contract, leading to potential investor losses [2]. Group 2: Shareholder Actions and Deadlines - Shareholders who purchased Ibotta shares during the specified class period are encouraged to register for the class action, with a deadline set for June 16, 2025 [3]. - Once registered, shareholders will receive updates on the case's progress through a portfolio monitoring software, and there is no cost to participate [3]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to misleading statements or omissions by companies, emphasizing the importance of responsible business practices [4].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Red Cat Holdings, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's production capacity and contract values [1][2]. Group 1: Allegations - The complaint alleges that during the class period from March 18, 2022, to January 15, 2025, Red Cat Holdings made materially false and misleading statements [1]. - Specific allegations include overstating the production capacity of the Salt Lake City Facility and the overall value of the U.S. Army's Short Range Reconnaissance Program of Record Tranche 2 contract [1]. Group 2: Class Action Details - Shareholders who purchased shares of RCAT during the specified class period are encouraged to register for the class action, with a deadline of July 22, 2025, to seek lead plaintiff status [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates on the case's progress [2]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [3]. - The firm seeks recovery for investors who suffered losses due to false or misleading statements that led to artificial inflation of stock prices [3].

Core Viewpoint - A class action lawsuit has been filed against Red Cat Holdings, Inc. for allegedly making false statements regarding its production capacity and contract values, impacting investor confidence and stock prices [1][3][6]. Company Overview - Red Cat Holdings, Inc. operates in the drone industry, providing products such as the "Teal 2" drone designed for military operations [2]. Allegations of the Lawsuit - The lawsuit claims that Red Cat overstated the production capacity of its Salt Lake City facility and the value of its Short Range Reconnaissance Program contract [3]. - On July 27, 2023, Red Cat disclosed that its Salt Lake City facility could only produce 100 drones per month, with potential future capacity of 1,000 drones per month contingent on further investments [4]. - Following this announcement, Red Cat's stock price fell nearly 9% [4]. Financial Performance - On September 23, 2024, Red Cat reported a loss per share of $0.17 for Q1 fiscal year 2025, missing estimates by $0.09, and revenue of $2.8 million, missing estimates by $1.07 million [5]. - The company admitted that retooling its Salt Lake City facility and a pause in manufacturing impacted Teal 2 sales, leading to a stock price drop of over 25% [5]. Additional Allegations - On January 16, 2025, a report from Kerrisdale Capital claimed that the SRR contract was smaller and less favorable than previously indicated by management, leading to a stock price decline of more than 21% over two trading sessions [6].